Home › Kanser sa Atay (Hepatocellular Carcinoma) › Florida › Jacksonville
Pag-aaral pangklinika para sa Kanser sa Atay (Hepatocellular Carcinoma) sa Jacksonville, FL
14 pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Jacksonville (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Nagre-recruitPhase 2
- Mayo Clinic in Florida, Jacksonville
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Nagre-recruitPhase 1
- Mayo Clinic Florida, Jacksonville
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #78, Jacksonville
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Nagre-recruitPhase 2
- Mayo Clinic in Florida, Jacksonville
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Nagre-recruitPhase 1/2
- Research Facility, Jacksonville
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Nagre-recruitPhase 3
- Research Site, Jacksonville
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Mayo Clinic in Florida, Jacksonville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Mayo Clinic, Jacksonville
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Nagre-recruitPhase 1
- Clinical Trial Site, Jacksonville
Intravital Microscopy in Human Solid Tumors
Nagre-recruit
- Mayo Clinic Florida, Jacksonville
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Nagre-recruitPhase 1
- Cancer Specialists of North Florida, Jacksonville
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Nagre-recruitObservasyonal na pag-aaral
- Mayo Clinic in Florida, Jacksonville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Jacksonville
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Nagre-recruitPhase 1/2
- Mayo Clinic in Florida, Jacksonville
Pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) sa ibang lungsod
- Houston, TX31 pag-aaral
- New York City, NY24 pag-aaral
- Dallas, TX19 pag-aaral
- Los Angeles, CA19 pag-aaral
- Boston, MA18 pag-aaral
- Cleveland, OH18 pag-aaral
- Philadelphia, PA16 pag-aaral
- Chicago, IL16 pag-aaral
- Pittsburgh, PA15 pag-aaral
- San Francisco, CA14 pag-aaral
- Orange, CA14 pag-aaral
- San Antonio, TX13 pag-aaral
Iba pang pag-aaral sa Jacksonville
- Kanser sa Suso40 pag-aaral
- Non-Small Cell Lung Cancer39 pag-aaral
- Kanser (lahat ng uri)29 pag-aaral
- Metastatic Cancer28 pag-aaral
- Colorectal Cancer27 pag-aaral
- Kanser sa Prostate26 pag-aaral
- Obesity25 pag-aaral
- Pagkabigo ng Puso21 pag-aaral
- Kanser sa Pancreas20 pag-aaral
- Overweight19 pag-aaral
- Multiple Myeloma18 pag-aaral
- Kanser sa Baga17 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.